Incorporation and conversion of icosapentaenoic acid (20:5, n -3) by human polymorphonuclear leukocytes were studied in volunteers (n -6) ingesting a normal Western diet supplemented with icosapentaenoic acid (=4 g daily). Ingestion of icosapentaenoic acid leads to formation of biologically less active leukotriene Bs (LTBs) from polymorphonuclear leukocytes (PMNL) Icosapentaenoic acid (20:5, n -3) predominates over arachidonic acid in marine diets and gives rise to trienoic icosanoids, which differ in biological activity from the dienoic icosanoids derived from arachidonic acid (4). Epidemiological and experimental studies suggest a therapeutic potential of icosapentaenoic acid-enriched diets in atherothrombotic and inflammatory disorders (5-9), and formation of icosapentaenoic acid-derived icosanoids has been implicated in those beneficial effects (10, 11 Preparation of PMNL. Heparinized venous blood (10 units/ml) was taken and centrifuged at 150 x g for 15 min. The platelet-rich plasma was discarded, and the blood was diluted with platelet-poor plasma (10% vol/vol), layered on a Percoil gradient, and centrifuged as described (14) . Contaminating cells were removed by hypotonic lysis and by washing the PMNL twice in bovine serum albumin (15 mg/dl). The PMNL fraction, resuspended in phosphate-buffered saline, was 98% pure with a viability of 97% and a leukocyte-toplatelet ratio greater than 80:1. Then, 10 ,AM ionophore A23187, dissolved in HBSS containing Ca2 , was added to give a final volume of 0.5 ml and a Ca2+ concentration of 0.8 mM. The incubation was terminated after 10 min by adding 1.5 vol of ice-cold ethanol.
corresponded to the ratio of arachidonic acid/icosapentaenoic acid in PMNL phospholipids. Our findings prove that LTBs, which is 10 to 30 times less potent than LTB4 to cause aggregation, chemotaxis, and degranulation of PMNL, can be formed in vivo in man after dietary icosapentaenoic acid. This may modify the contribution of leukotrienes in processes in which these metabolites are of pathogenetic relevance.
Human polymorphonuclear leukocytes (PMNL) convert arachidonic acid (20:4, n -6) after release from cellular phospholipids to leukotriene B4 (LTB4) via the 5-lipoxygenase pathway (1, 2) . LTB4 is a potent stimulator of PMNL chemotaxis and, therefore, an important component of the cellular response in inflammatory and immune reactions (3) . Under Icosapentaenoic acid (20:5, n -3) predominates over arachidonic acid in marine diets and gives rise to trienoic icosanoids, which differ in biological activity from the dienoic icosanoids derived from arachidonic acid (4) . Epidemiological and experimental studies suggest a therapeutic potential of icosapentaenoic acid-enriched diets in atherothrombotic and inflammatory disorders (5) (6) (7) (8) (9) , and formation of icosapentaenoic acid-derived icosanoids has been implicated in those beneficial effects (10, 11) . Indeed, in vitro synthesized LTB5 is at least 1 order of magnitude less potent in stimulating PMNL chemotaxis and aggregation (12, 13 Preparation of PMNL. Heparinized venous blood (10 units/ml) was taken and centrifuged at 150 x g for 15 min. The platelet-rich plasma was discarded, and the blood was diluted with platelet-poor plasma (10% vol/vol), layered on a Percoil gradient, and centrifuged as described (14) . Contaminating cells were removed by hypotonic lysis and by washing the PMNL twice in bovine serum albumin (15 mg/dl). The PMNL fraction, resuspended in phosphate-buffered saline, was 98% pure with a viability of 97% and a leukocyte-toplatelet ratio greater than 80:1. Then, 10 ,AM ionophore A23187, dissolved in HBSS containing Ca2 , was added to give a final volume of 0.5 ml and a Ca2+ concentration of 0.8 mM. The incubation was terminated after 10 min by adding 1.5 vol of ice-cold ethanol.
Extraction, Purification, and Analysis of LTB4 and LTB5.
The ethanolic solution was centrifuged, purified, and extracted using SEP-PAK C18 cartridges as described (15) . Reversed-phase (RP)-HPLC was carried out with a Nucleosil 5 C18 column using MeOH/H20/acetic acid, 70:30:0.01 (vol/ vol; pH adjusted to 5.7 with NH4OH) as the mobile phase at 1 ml/min. For quantification of biosynthesized LTB4 and LTB5, PG132 (100 ng) or [3H]LTB4 (2 x 105 cpm) were added to the sample before extraction to account for recovery. Absorbance was monitored at 280 nm; radioactivity was measured by using a radioactivity monitor.
LTB4 and LTB5 and the corresponding 6-trans isomers of Abbreviations: PMNL, polymorphonuclear leukocytes; RP-HPLC, reversed-phase HPLC; LTB4 and LTB5, leukotrienes B4 and B5, respectively; HBSS, Hank's balanced salt solution; PGB2, prostaglandin B2. *To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. each compound were separated, and the Me,Me3Si-derivatives were further analyzed by GC/MS. The GC/MS system was a Finnigan MAT 44s, equipped with a 50-m fused silica WCOT capillary column (Carbowax CP 51; Chrompack) capable of separating LTB4 and LTB5. Retention times were 13.1 min for LTB4 and 14.5 min for LTB5. Operation conditions of the GC/MS system were: injection port, 280°C; interface, 270°C; ion source, 200°C; electron impact energy, 80 eV; current of emission, 0.9 mA; electron multiplier voltage, 1.8 kV.
Fatty Acid Analyses. Phospholipid fatty acids were analyzed by GC as described (16) . Briefly, a Packard gas chromatograph was used (model 419), equipped with a 6-foot glass column, containing 10o SP-2340 on 100-120 mesh (Supelco, Munich, F.R.G.). Carrier gas had a flow rate of 25 ml/min, oven temperature was 150-200°C, the rise in temperature was 2°C/min, and the injection port was at 270°C. Tables 1 and 2 ).
RESULTS

DISCUSSION
Our study shows that LTB5, the 5-lipoxygenase product of icosapentaenoic acid, is synthesized in human PMNL from endogenous icosapentaenoic acid incorporated into cellular phospholipids during dietary supplementation. The identity of LTB5 was proven by RP-HPLC and GC/MS. It was shown that LTB5 synthesized by human PMNL from endogenous icosapentaenoic acid has the same characteristics as Values are means ± SD from six volunteers. ND, not detectable.
LTB5 produced by PMNL in vitro from exogenous icosapentaenoic acid: identical retention times on RP-HPLC ( Fig. 1 Middle and Bottom) and on capillary GC (14.5 min) and identical fragmentation patterns on MS (Fig. 2) . A similar behavior on HPLC and GC/MS has been described for LTB5 synthesized from icosapentaenoic acid in a mouse mastocytoma cell line (17) . Proc. Nad Acad Sci. USA 82 (1985) acids with icosapentaenoic acid for common binding positions in PMNL phospholipids. Comparison of the conversion rates of cellular arachidonic acid and icosapentaenoic acid in PMNL after the icosapentaenoic acid-enriched diet demonstrates that transformation of cellular arachidonic acid and icosapentaenoic acid to LTB4 and LTB5 occurs at a comparable rate (Tables 1 and 2 ).
The biological effects of LTB4, the 5-lipoxygenase product derived from arachidonic acid, towards human PMNL include chemokinesis and chemotaxis, aggregation, release of lysosomal enzymes, and stimulation of superoxide anion production (3, 18) . They show the fundamental importance of LTB4 in physiological and pathological responses of PMNL in processes like inflammation and immunological reactions. In two recent studies, LTB5, synthesized from icosapentaenoic acid in vitro, was shown to possess only 1/10th to 1/30th of the chemotactic and aggregatory potency towards human PMNL as compared to LTB4 (12, 13) . This demonstrates the functionally reduced activity of LTB5 in its agonist action on human PMNL. Epidemiological and experimental studies suggest that changes in the natural history of atherothrombotic and inflammatory disorders may be achieved by altering the icosanoid precursor availability (5) (6) (7) (8) (9) . Formation of icosapentaenoic acid-derived icosanoids with a desirable spectrum of biological activities has been implicated in those beneficial effects (10, 11) .
In our short term study, arachidonic acid in PMNL phospholipids was only slightly reduced. This could be one reason for the unreduced formation of LTB4 in washed PMNL after the icosapentaenoic acid-supplemented diet. Recent animal experiments suggest that a longer dietary supplementation of icosapentaenoic acid will decrease cellular arachidonic acid to a greater extent, with a concomitant decrease of LTB4 formation (17, 19) . In contrast to these animal experiments in which the normal n -6 fatty acid diet was completely replaced by a n -3 fatty acid diet, in our experiments an otherwise unchanged Western diet was supplemented with icosapentaenoic acid. The intake of n -6 polyunsaturated fatty acids, including arachidonic acid, remained unchanged during the supplementation period. The present results, which prove the synthesis of LTB5 in human PMNL from endogenous icosapentaenoic acid after dietary supply, in conjunction with previous animal experiments and in vitro studies, suggest that a long-term enrichment of our Western nutrition with higher doses of icosapentaenoic acid may modify the contribution of leukotrienes in reactions in which these products are of pathogenetic relevance.
